Page last updated: 2024-08-21

alpha-aminopyridine and Glucose Metabolic Disorder

alpha-aminopyridine has been researched along with Glucose Metabolic Disorder in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, L; Chiang, SH; Decker, SJ; Downes, M; Evans, RM; Hochberg, I; Larsen, MJ; Li, P; Liddle, C; Mowers, J; Oh, D; Olefsky, JM; Reilly, SM; Rubin, JR; Saltiel, AR; Uhm, M; White, NM; Yu, RT	1

Other Studies

1 other study(ies) available for alpha-aminopyridine and Glucose Metabolic Disorder

Article	Year
An inhibitor of the protein kinases TBK1 and IKK-ɛ improves obesity-related metabolic dysfunctions in mice. Nature medicine, 2013, Volume: 19, Issue:3 Topics: Aminopyridines; Animals; Anti-Allergic Agents; Anti-Obesity Agents; Cell Line; Diet, High-Fat; Energy Metabolism; Enzyme Activation; Fatty Liver; Glucose Metabolism Disorders; I-kappa B Kinase; Insulin Resistance; Intra-Abdominal Fat; Male; Mice; Mice, Inbred C57BL; Mice, Obese; NF-kappa B; Obesity; Oxygen Consumption; Protein Serine-Threonine Kinases; Weight Loss	2013

Article

Year

An inhibitor of the protein kinases TBK1 and IKK-ɛ improves obesity-related metabolic dysfunctions in mice.

Nature medicine, 2013, Volume: 19, Issue:3

Topics: Aminopyridines; Animals; Anti-Allergic Agents; Anti-Obesity Agents; Cell Line; Diet, High-Fat; Energy Metabolism; Enzyme Activation; Fatty Liver; Glucose Metabolism Disorders; I-kappa B Kinase; Insulin Resistance; Intra-Abdominal Fat; Male; Mice; Mice, Inbred C57BL; Mice, Obese; NF-kappa B; Obesity; Oxygen Consumption; Protein Serine-Threonine Kinases; Weight Loss

2013